Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012

Paul Anantharajah Tambyah, Gabriel Levy Hara, George L. Daikos, Matthew E. Falagas, Teresita Mazzei, Johan W. Mouton, Andrea Novelli, Baiyi Chen, Minggui Wang, Wen Chien Ko, Taisheng Li, Xinjian Fan, Ursula Theuretzbacher

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

Infections caused by multidrug-resistant and extensively drug-resistant Gram-negative bacilli are increasingly challenging to manage in hospitals and long term-care facilities worldwide. As the therapeutic options are limited, the International Society of Chemotherapy in collaboration with the Asia-Pacific Society of Clinical Microbiology and Immunology organised a consensus conference as part of the 13th Asia-Pacific Congress of Clinical Microbiology and Infection. A panel of international experts from Europe, the Americas and Asia were convened to discuss the issues of therapeutic options for the management of these difficult-to-treat pathogens.

Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalJournal of Global Antimicrobial Resistance
Volume1
Issue number3
DOIs
Publication statusPublished - 2013 Aug 26

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology and Allergy
  • Immunology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012'. Together they form a unique fingerprint.

Cite this